BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28141486)

  • 1. Usefulness of humanized cDNA-uPA/SCID mice for the study of hepatitis B virus and hepatitis C virus virology.
    Uchida T; Imamura M; Kan H; Hiraga N; Hayes CN; Tsuge M; Abe-Chayama H; Aikata H; Makokha GN; Miki D; Ochi H; Ishida Y; Tateno C; Chayama K
    J Gen Virol; 2017 May; 98(5):1040-1047. PubMed ID: 28141486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections.
    Kosaka K; Hiraga N; Imamura M; Yoshimi S; Murakami E; Nakahara T; Honda Y; Ono A; Kawaoka T; Tsuge M; Abe H; Hayes CN; Miki D; Aikata H; Ochi H; Ishida Y; Tateno C; Yoshizato K; Sasaki T; Chayama K
    Biochem Biophys Res Commun; 2013 Nov; 441(1):230-5. PubMed ID: 24140055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel cDNA-uPA/SCID/Rag2
    Uchida T; Teraoka Y; Imamura M; Abe-Chayama H; Makokha GN; Hayes CN; Aikata H; Hamamura S; Ishida Y; Tateno C; Shirouzu T; Kawai S; Tanaka Y; Ohdan H; Okada S; Chayama K
    J Viral Hepat; 2023 Mar; 30(3):262-272. PubMed ID: 36575861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice.
    Vanwolleghem T; Libbrecht L; Hansen BE; Desombere I; Roskams T; Meuleman P; Leroux-Roels G
    J Hepatol; 2010 Sep; 53(3):468-76. PubMed ID: 20591528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric mouse model for the infection of hepatitis B and C viruses.
    Tesfaye A; Stift J; Maric D; Cui Q; Dienes HP; Feinstone SM
    PLoS One; 2013; 8(10):e77298. PubMed ID: 24155939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection.
    Klumpp K; Shimada T; Allweiss L; Volz T; Lütgehetmann M; Hartman G; Flores OA; Lam AM; Dandri M
    Gastroenterology; 2018 Feb; 154(3):652-662.e8. PubMed ID: 29079518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV.
    Meuleman P; Leroux-Roels G
    Antiviral Res; 2008 Dec; 80(3):231-8. PubMed ID: 18706933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propagation of Human Hepatocytes in uPA/SCID Mice: Producing Chimeric Mice with Humanized Liver.
    Ohshita H; Tateno C
    Methods Mol Biol; 2017; 1506():91-100. PubMed ID: 27830547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.
    Lütgehetmann M; Mancke LV; Volz T; Helbig M; Allweiss L; Bornscheuer T; Pollok JM; Lohse AW; Petersen J; Urban S; Dandri M
    Hepatology; 2012 Mar; 55(3):685-94. PubMed ID: 22031488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera.
    Meuleman P; Libbrecht L; De Vos R; de Hemptinne B; Gevaert K; Vandekerckhove J; Roskams T; Leroux-Roels G
    Hepatology; 2005 Apr; 41(4):847-56. PubMed ID: 15791625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of Novel Chimeric Mice with Humanized Livers by Using Hemizygous cDNA-uPA/SCID Mice.
    Tateno C; Kawase Y; Tobita Y; Hamamura S; Ohshita H; Yokomichi H; Sanada H; Kakuni M; Shiota A; Kojima Y; Ishida Y; Shitara H; Wada NA; Tateishi H; Sudoh M; Nagatsuka S; Jishage K; Kohara M
    PLoS One; 2015; 10(11):e0142145. PubMed ID: 26536627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse.
    Vanwolleghem T; Meuleman P; Libbrecht L; Roskams T; De Vos R; Leroux-Roels G
    Gastroenterology; 2007 Oct; 133(4):1144-55. PubMed ID: 17919490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human hepatocytes secrete soluble CD14, a process not directly influenced by HBV and HCV infection.
    Meuleman P; Steyaert S; Libbrecht L; Couvent S; Van Houtte F; Clinckspoor F; de Hemptinne B; Roskams T; Vanlandschoot P; Leroux-Roels G
    Clin Chim Acta; 2006 Apr; 366(1-2):156-62. PubMed ID: 16253217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hepatitis B virus infection in humanized chimeric mice has multiphasic viral kinetics.
    Ishida Y; Chung TL; Imamura M; Hiraga N; Sen S; Yokomichi H; Tateno C; Canini L; Perelson AS; Uprichard SL; Dahari H; Chayama K
    Hepatology; 2018 Aug; 68(2):473-484. PubMed ID: 29572897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of human hepatocyte transplantation in a SCID/uPA mouse model with inducible liver disease.
    Douglas DN; Kawahara T; Sis B; Bond D; Fischer KP; Tyrrell DL; Lewis JT; Kneteman NM
    PLoS One; 2010 Feb; 5(2):e9209. PubMed ID: 20174638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal model for study of human hepatitis viruses.
    Chayama K; Hayes CN; Hiraga N; Abe H; Tsuge M; Imamura M
    J Gastroenterol Hepatol; 2011 Jan; 26(1):13-8. PubMed ID: 21175788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong antiviral activity of the new l-hydroxycytidine derivative, l-Hyd4FC, in HBV-infected human chimeric uPA/SCID mice.
    Volz T; Lütgehetmann M; Allweiss L; Warlich M; Bierwolf J; Pollok JM; Petersen J; Matthes E; Dandri M
    Antivir Ther; 2012; 17(4):623-31. PubMed ID: 22368233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes.
    Sugiyama M; Tanaka Y; Kurbanov F; Maruyama I; Shimada T; Takahashi S; Shirai T; Hino K; Sakaida I; Mizokami M
    Gastroenterology; 2009 Feb; 136(2):652-62.e3. PubMed ID: 19041311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of humanized mice for the study of hepatitis C virus infection.
    Turrini P; Sasso R; Germoni S; Marcucci I; Celluci A; Di Marco A; Marra E; Paonessa G; Eutropi A; Laufer R; Migliaccio G; Padron J
    Transplant Proc; 2006 May; 38(4):1181-4. PubMed ID: 16757300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Property of hepatitis B virus replication in Tupaia belangeri hepatocytes.
    Sanada T; Tsukiyama-Kohara K; Yamamoto N; Ezzikouri S; Benjelloun S; Murakami S; Tanaka Y; Tateno C; Kohara M
    Biochem Biophys Res Commun; 2016 Jan; 469(2):229-35. PubMed ID: 26654952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.